Age related seroprevalence of antibodies to varicella in India.
dc.contributor.author | Lokeshwar, M R | en_US |
dc.contributor.author | Agrawal, A | en_US |
dc.contributor.author | Subbarao, S D | en_US |
dc.contributor.author | Chakraborty, M S | en_US |
dc.contributor.author | Ram Prasad, A V | en_US |
dc.contributor.author | Weil, J | en_US |
dc.contributor.author | Bock, H L | en_US |
dc.contributor.author | Kanwal, S | en_US |
dc.contributor.author | Shah, R C | en_US |
dc.contributor.author | Shah, N | en_US |
dc.date.accessioned | 2000-07-25 | en_US |
dc.date.accessioned | 2009-05-27T04:56:30Z | |
dc.date.available | 2000-07-25 | en_US |
dc.date.available | 2009-05-27T04:56:30Z | |
dc.date.issued | 2000-07-25 | en_US |
dc.description.abstract | OBJECTIVE: To determine the age related prevalence of Varicella Zoster Virus (VZV) antibodies in India. SETTING: This was a cross sectional multicentric study performed in 4 major cities of India: Calcutta (outpatients), Mumbai (outpatients), Lucknow (walk-in patients to a diagnostic laboratory, orphanage and factory workers) and Bangalore (outpatients and walk-in patients to a diagnostic laboratory). METHODS: A total of 1609 volunteers from birth to 40 years of age were included into the study. IgG antibodies against VZV were determined using commercial kits (ELISA-Enzygnost). RESULTS: Overall seroprevalence of anti VZV antibodies was 68. 22percnt. The age related seroprevalence rate of anti VZV antibodies was 29percnt in the age group of 1-5 years, 51.1percnt in 5-10 years, 71.7percnt in 11-15 years, 79.8percnt in 16-20 years, 88.1percnt in 21-30 years and 91.1percnt in 31-40 years. CONCLUSION: A significant proportion of adolescents and adults are susceptible to varicella in India, as in other tropical countries | en_US |
dc.description.affiliation | Hinduja Hospital, Mumbai, India. | en_US |
dc.identifier.citation | Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, Bock HL, Kanwal S, Shah RC, Shah N. Age related seroprevalence of antibodies to varicella in India. Indian Pediatrics. 2000 Jul; 37(7): 714-9 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/6631 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianpediatrics.net | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Age Distribution | en_US |
dc.subject.mesh | Chickenpox --epidemiology | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Cross-Sectional Studies | en_US |
dc.subject.mesh | Herpesvirus 3, Human --immunology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | India --epidemiology | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Infant, Newborn | en_US |
dc.subject.mesh | Seroepidemiologic Studies | en_US |
dc.title | Age related seroprevalence of antibodies to varicella in India. | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |
Files
License bundle
1 - 1 of 1